Menu
Subscribe to our Email Alerts
About Us
Island at a glance
Board
Key Management
Scientific Advisory Board
Collaborations
Science
About ISLA-101
Scientific Publications
Drug repurposing and benefits
Disease and drug terms explained
Investor Centre
Investor Welcome
Clinical programme
ASX Announcements
Financial Reports
Share Price Information
Shareholder Services
Investor Fact Sheet
Corporate Governance
Corporate Directory
International Investors
Research Coverage
AGM
Media
News
Presentations
Contact
Contact Us
Subscribe for Email Alerts
Investor Centre
Investor Centre
>
ASX Announcements
Investor Welcome
Clinical programme
ASX Announcements
Financial Reports
Share Price Information
Shareholder Services
Investor Fact Sheet
Corporate Governance
Corporate Directory
International Investors
Research Coverage
AGM
ASX Announcements
Filter by Year:
2023
2022
2021
26-Sep-2023
Date of AGM & Closing Date for Director Nominations
25-Sep-2023
ISLA-101 Single Ascending Dose study update
13-Sep-2023
Island Pharmaceuticals granted key U.S. patent for ISLA-101
30-Aug-2023
Appendix 4G
30-Aug-2023
Corporate Governance Statement
30-Aug-2023
Appendix 4E & Annual Report
31-Jul-2023
Quarterly Activity Report & Appendix 4C
7-Jul-2023
US grant funding to support ISLA-101 clinical development
16-May-2023
Island receives FDA go-ahead for ISLA-101 program
27-Apr-2023
Replacement - Change in substantial holding
1
2
3
Next
.png){kind=logo}
